The influence of ethanolic extracts of Brassica campestris spp. rapa roots (EBR) on obesity was examined in imprinting control region (ICR) mice fed a high-fat diet (HFD) and in 3T3-L1 adipocytes. The ICR mice used were divided into regular diet, HFD, EBR (50 mg/kg/day EBR administered orally), and orlistat (10 mg/kg/day orlistat administered orally) groups. The molecular mechanism of the anti-obesity effect of EBR was investigated in 3T3-L1 adipocytes as well as in HFD-fed ICR mice. In the obese mouse model, both weight gain and epididymal fat accumulation were highly suppressed by the daily oral administration of 50 mg/kg EBR for 8 weeks, whereas the overall amount of food intake was not affected. EBR treatment induced the expression in white adipocytes of lipolysis-related genes, including β3-adrenergic receptor (β3-AR), hormone-sensitive lipase (HSL), adipose triglyceride lipase, and uncoupling protein 2. Furthermore, the activation of cyclic AMP-dependent protein kinase, HSL, and extracellular signal-regulated kinase was induced in EBR-treated 3T3-L1 cells. The lipolytic effect of EBR involved β3-AR modulation, as inferred from the inhibition by the β3-AR antagonist propranolol. These results suggest that EBR may have potential as a safe and effective anti-obesity agent via the inhibition of adipocyte lipid accumulation and the stimulation of β3-AR-dependent lipolysis.
Get full access to this article
View all access options for this article.
References
1.
KopelmanPG. Obesity as a medical problem. Nature, 2000; 404:635–643.
2.
PadwalRS, MajumdarSR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet, 2007; 369:71–77.
3.
ChapmanMJ. Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives. Atherosclerosis, 2003; 171:1–13.
4.
BrayGA. Drug treatment of obesity. Rev Endocr Metab Disord, 2001; 2:403–418.
5.
DeyL, ZhangL, YuanCS. Anti-diabetic and anti-obese effects of ginseng berry extract: comparison between intraperitoneal and oral administrations. Am J Chin Med, 2002; 30:645–647.
6.
KangM, OhJW, LeeHKet al.Anti-obesity effect of PM-F2-OB, an anti-obesity herbal formulation, on rats fed a high-fat diet. Biol Pharm Bull, 2004; 27:1251–1256.
7.
LafontaineJA, DayRF, DibrinoJet al.Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity. Bioorg Med Chem Lett, 2007; 17:5245–5250.
8.
ZhangY, MathenyM, ZolotukhinSet al.Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta, 2002; 1584:115–122.
WattMJ, HolmesAG, PinnamaneniSKet al.Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab, 2006; 290:E500–E508.
12.
LondosC, BrasaemleDL, SchultzCJet al.ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol, 1999; 10:51–58.
13.
ChoKJ, ShimJH, ChoMCet al.Signaling pathways implicated in alpha-melanocyte stimulating hormone-induced lipolysis in 3T3-L1 adipocytes. J Cell Biochem, 2005; 96:869–878.
14.
KimJS, ChoiYH, LeeJWet al.Chemical constituents from the roots of Brassica campestris ssp rapa. J Korean Soc Appl Biol Chem, 2004; 35:259–263.
15.
BangMH, LeeDY, HanMWet al.Development of biologically active compounds from edible plant sources—XX: Isolation of lipids from the roots of Brassica campestris ssp rapa. J Korean Soc Appl Biol Chem, 2007; 50:233–237.
16.
BangMH, LeeDY, OhYJet al.Development of biological active compound from edible plant sources XXII. Isolation of indoles from the roots of Braccica campestris spp rapa and their hACAT inhibitory activity. J Korean Soc Appl Biol Chem, 2008; 51:65–69.
17.
JungUJ, BaekNI, ChungHGet al.Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice. Clin Nutr, 2008; 27:158–167.
18.
KimYH, KimYW, OhYJet al.Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats. Biol Pharm Bull, 2006; 29:2436–2441.
19.
WolfeK, WuX, LiuRH. Antioxidant activity of apple peels. J Agric Food Chem, 2003; 51:609–614.
20.
AhimaRS. Adipose tissue as an endocrine organ. Obesity (Silver Spring), 2006; 14,Suppl 5:242S–249S.
21.
LuoS, WehrNB, LevineRL. Quantitation of protein on gels and blots by infrared fluorescence of Coomassie blue and Fast Green. Anal Biochem, 2006; 350:233–238.
22.
StrålforsP, BjörgellP, BelfrageP. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. Proc Natl Acad Sci USA, 1984; 81:3317–3321.
23.
GreenbergAS, ShenWJ, MuliroKet al.Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem, 2001; 276:45456–45461.
24.
FredriksonG, StrålforsP, NilssonNO, BelfrageP. Hormone-sensitive lipase of rat adipose tissue. Purification and some properties. J Biol Chem, 1981; 256:6311–6320.
25.
BrasaemleDL, LevinDM, Adler-WailesDC, LondosC. The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. Biochim Biophys Acta, 2000; 1483:251–262.
26.
KhovidhunkitW, KimMS, MemonRAet al.Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res, 2004; 45:1169–1196.
27.
LargeV, ReynisdottirS, LanginDet al.Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res, 1999; 40:2059–2066.
28.
FleuryC, NeverovaM, CollinsSet al.Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet, 1997; 15:269–272.
29.
PangJ, ChoiY, ParkT. Ilex paraguariensis extract ameliorates obesity induced by high-fat diet: potential role of AMPK in the visceral adipose tissue. Arch Biochem Biophys, 2008; 276:178–185.
30.
Erlanson-AlbertssonC. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand, 2003; 178:405–412.
31.
HolmC, OsterlundT, LaurellH, ContrerasJA. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr, 2000; 20:365–393.
32.
EganJJ, GreenbergAS, ChangMKet al.Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet. Proc Natl Acad Sci U S A, 1992; 89:8537–8541.
33.
CliffordGM, LondosC, KraemerFBet al.Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. J Biol Chem, 2000; 275:5011–5015.
34.
GreenbergAS, ShenWJ, MuliroKet al.Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem, 2001; 276:45456–45461.
35.
TontonozP, HuE, GravesRAet al.mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev, 1994; 8:1224–1234.
36.
YajimaH, KobayashiY, KanayaT, HorinoY. Identification of peroxisome-proliferator responsive element in the mouse HSL gene. Biochem Biophys Res Commun, 2007; 352:526–531.
37.
FestucciaWT, LaplanteM, BerthiaumeMet al.PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia, 2006; 49:2427–2436.
38.
BurnsKA, Vanden HeuvelJP. Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta, 2007; 1771:952–960.
